Data as of Jul 24
| -0.003 / -0.64%|
The 1 analysts offering 12-month price forecasts for Cleveland Biolabs Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +326.53% increase from the last price of 0.47.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.